Additionally, FGF19 in MSC-derived exosomes promotes NPC progression by activating the FGF19-FGFR4-ERK signaling pathway and modulating EMT, thereby influencing NPC cells through exosome interaction. The gene discussed is FGF19; the disease is nasopharyngeal carcinoma.